A P Schwarer
Overview
Explore the profile of A P Schwarer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
653
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hughes T, Leber B, Cervantes F, Spector N, Pasquini R, Clementino N, et al.
Leukemia
. 2017 Sep;
31(11):2529-2531.
PMID: 28862704
No abstract available.
2.
Schwarer A, Bollard G, Kapuscinski M, Muirhead J, Diviney M, Hart C, et al.
Bone Marrow Transplant
. 2010 Dec;
46(10):1331-8.
PMID: 21151186
Advanced haematological malignancies are incurable without allogeneic haematopoietic SCT (HSCT). Many patients do not have a human leukocyte Ag (HLA)-matched donor; hence, haploidentical HSCT has been explored for some 20...
3.
Ross D, Branford S, Seymour J, Schwarer A, Arthur C, Bartley P, et al.
Leukemia
. 2010 Sep;
24(10):1719-24.
PMID: 20811403
Around 40-50% of patients with chronic myeloid leukemia (CML) who achieve a stable complete molecular response (CMR; undetectable breakpoint cluster region-Abelson leukemia gene human homolog 1 (BCR-ABL1) mRNA) on imatinib...
4.
Hiwase D, Hiwase S, Bailey M, Bollard G, Schwarer A
Cytotherapy
. 2008 Jul;
10(5):507-17.
PMID: 18608354
Background: The lymphocyte dose (LY-DO) infused during an autograft influences absolute lymphocyte (ALC) recovery and survival following autologous stem cell transplantation (ASCT) in multiple myeloma (MM) patients. Factors influencing lymphocyte...
5.
Hiwase D, Bollard G, Hiwase S, Bailey M, Muirhead J, Schwarer A
Cytotherapy
. 2007 Sep;
9(6):539-47.
PMID: 17882718
Background: Autologous PBSC transplantation is the standard care for patients with multiple myeloma. The most common regimen used to mobilize PBSC consists of CY and G-CSF. Methods: We retrospectively analyzed...
6.
Slavin M, Grigg A, Schwarer A, Szer J, Spencer A, Sainani A, et al.
Bone Marrow Transplant
. 2007 May;
40(2):157-63.
PMID: 17468774
We performed a randomized comparison of pre-emptive and empiric antibiotic therapy for adult patients undergoing allogeneic or autologous stem cell transplantation. One hundred and fifty-three patients were randomized to receive...
7.
Morrissey C, Slavin M, OReilly M, Daffy J, Seymour J, Schwarer A, et al.
Mycoses
. 2007 Mar;
50 Suppl 1:24-37.
PMID: 17394607
Caspofungin (CAS) has shown efficacy as salvage monotherapy for invasive aspergillosis (IA) in two open label non-comparative trials. The association between hepatotoxicity and concomitant use of CAS and cyclosporin A...
8.
Etto T, Stewart L, Muirhead J, Bailey M, Schwarer A
Tissue Antigens
. 2007 Jan;
69(1):56-61.
PMID: 17212708
In the human leucocyte antigen (HLA)-matched haematopoietic stem cell transplantation (HSCT) setting, minor histocompatibility antigen (mHA) disparities between recipient and donor can lead to graft-vs-host disease (GVHD) or graft rejection....
9.
Bow E, Rotstein C, Noskin G, Laverdiere M, Schwarer A, Segal B, et al.
Clin Infect Dis
. 2006 Jul;
43(4):447-59.
PMID: 16838234
Background: The empirical treatment of febrile, neutropenic patients with cancer requires antibacterial regimens active against both gram-positive and gram-negative pathogens. This study was performed to demonstrate the noninferiority of monotherapy...
10.
Grigg A, Shuttleworth P, Reynolds J, Schwarer A, Szer J, Bradstock K, et al.
J Clin Endocrinol Metab
. 2006 Jul;
91(10):3835-43.
PMID: 16835281
Background: Rapid bone loss occurs from the proximal femur after allogeneic stem cell transplantation (alloSCT). Objective: The objective of the study was to evaluate effects of high-dose pamidronate therapy on...